Evidence map›Paper›PMID 40832316›Full record

ArticlebioRxiv : the preprint server for biology2025

MechanoAge, a machine learning platform to identify individuals susceptible to breast cancer based on mechanical properties of single cells.

Stefan Hinz, Sturla M Grøndal, Masaru Miyano, Jennifer C Lopez, Kristen L Cotner, Taylor Thomsen, Chang Chen, Edward J Hester, Lisa D Yee, Victoria E Seewaldt and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Stefan HinzDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.ORCID 0000-0003-3184-2983
Sturla M GrøndalDepartment of Biomedicine & Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.
Masaru MiyanoDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.ORCID 0000-0002-1490-4743
Jennifer C LopezDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Kristen L CotnerUC Berkeley-UC San Francisco Graduate Program in Bioengineering, University of California, Berkeley, CA, USA.ORCID 0000-0003-3696-7400
Taylor ThomsenUC Berkeley-UC San Francisco Graduate Program in Bioengineering, University of California, Berkeley, CA, USA.
Chang ChenDepartment of Mechanical Engineering, University of California, Berkeley, CA, USA.
Edward J HesterDepartment of Mechanical Engineering, University of California, Berkeley, CA, USA.
Lisa D YeeDepartment of Surgery, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.ORCID 0000-0001-8243-1055
Victoria E SeewaldtDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.ORCID 0000-0002-7289-9268
James B LorensDepartment of Biomedicine & Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.
Lydia L SohnDepartment of Mechanical Engineering, University of California, Berkeley, CA, USA.ORCID 0000-0003-2195-2521
Mark A LaBargeDepartment of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.ORCID 0000-0003-2405-4719

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
Mechanical Phenotyping of Random Periaerolar Fine Needle Aspiration-Collected Cells for Early Breast Cancer DetectionR01EB024989 · NIBIB · UNIVERSITY OF CALIFORNIA BERKELEY · PI Mark A LaBarge, Lydia L Sohn · 2017 to 2026
$4.8M
Understanding breast cancer progression as a defect in the mechanics of tissue self-organizationU01CA244109 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARTNER, ZEV JORDAN, GOGA, ANDREI · 2020 to 2024
$3.0M
Involution-based biomarkers of breast cancer riskR01CA237602 · NCI · MAYO CLINIC JACKSONVILLE · PI DEGNIM, AMY C, RADISKY, DEREK C · 2020 to 2024
$2.8M
NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA237602NCI NIH HHS U01 CA244109NIBIB NIH HHS R01 EB024989
6 · The paper itself

Abstract

Background: Existing breast cancer risk models inadequately identify individuals at latent risk, particularly among women without known genetic mutations or family history. Risk is often underestimated or overestimated due to reliance on population-level data and neglect of cellular aging and mechanobiological alterations. Methods: We profiled primary human mammary epithelial cells (HMECs) from women of varying ages and risk backgrounds using mechano-node-pore sensing (mechano-NPS), a high-throughput microfluidic platform that captures single-cell mechanical properties. Using machine learning, we developed a classifier, MechanoAge, to predict age-related mechanical phenotypes and introduce a novel index, mechano-RISQ, to quantify deviations linked to breast cancer risk. We further assessed the cytoskeletal protein keratin 14 (KRT14) as a molecular mediator of these mechanical states through overexpression and knockdown experiments. Findings: Cells from younger women carrying BRCA1/2 mutations or with a family history of breast cancer exhibited accelerated mechanical aging compared to age-matched controls. Elevated mechano-RISQ scores reflected an increased proportion of cells with "older" mechanical profiles. KRT14 overexpression induced an aged mechanical phenotype in younger cells, while knockdown partially reversed this state in older cells. CyTOF profiling and modeling showed KRT14 modulation impacted protein expression signatures associated with aging and risk, particularly in luminal cells. Interpretation: Mechanical properties of breast epithelial cells reflect biologic aging and cancer susceptibility. Mechano-RISQ offers a new approach for identifying individuals at elevated risk, especially among average-risk populations, and may complement existing risk models by incorporating biophysical measures of epithelial aging.

Indexed as

Breast Cancer RiskKeratin-14 RemodelingMachine LearningMicrofluidic Node-Pore SensingSingle-Cell Mechanical Phenotyping

Identifiers

PMID40832316
PMCPMC12363770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.